• TCAIM Regulates Mitochondrial Metabolism by Targeting OGDH

  2026-06-11

  Wang et al. (2025) identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels, thereby modulating mitochondrial metabolism and energy production. This study unveils a noncanonical, post-translational mechanism for controlling a key TCA cycle enzyme, with implications for targeted metabolic research and disease modeling.

• Fenofibrate: PPARα Agonist Mechanisms and Age-Independent Ef

  2026-06-11

  Fenofibrate is a potent PPARα agonist that activates the PPARα-YAP pathway in both adult and aging mice, inducing liver enlargement without age-dependent differences. This article details its mechanism, experimental benchmarks, and caveats for lipid metabolism and cancer biology research.

• Sulfachloropyridazine Modulates Cecal Microbiota in Eimeria

  2026-06-10

  The referenced study investigates how sulfachlorpyridazine, ethanamizuril, and their combination reshape the cecal microbiota and metabolome in chickens infected with Eimeria tenella. By integrating 16S rRNA sequencing and metabolomics, the research reveals how these interventions influence microbial community structure and metabolic responses, informing future avian infection models and therapeutic strategies.

• ECL Chemiluminescent Substrate Detection Kit: Enhanced Assay

  2026-06-10

  The ECL Chemiluminescent Substrate Detection Kit (Enhanced) from APExBIO delivers ultra-sensitive western blot chemiluminescence detection, making it ideal for low-abundance protein quantification and robust antibody detection assays. This guide bridges practical workflow improvements and troubleshooting strategies to maximize signal amplification and reproducibility across advanced protein immunodetection studies.

• O-GlcNAcylation Regulates Wnt-Driven Bone Formation via Glyc

  2026-06-09

  This study reveals that O-GlcNAcylation is essential for Wnt-stimulated bone formation by regulating aerobic glycolysis in osteoblasts. The findings clarify metabolic mechanisms underpinning osteogenesis and suggest new targets for osteoporosis therapies.

• Wnt and BMP Pathways Pattern Neuroectoderm in Hemichordates

  2026-06-09

  This study reveals how Wnt and BMP signaling gradients orchestrate anterior neuroectoderm development in the indirect-developing hemichordate Ptychodera flava. By dissecting spatial and temporal gene expression, the work clarifies evolutionarily conserved mechanisms of axis patterning in deuterostomes, informing both developmental biology and translational research on Wnt signaling modulation.

• Dissecting In Vitro Metrics for Cancer Drug Response Evaluat

  2026-06-08

  Schwartz (2022) advances cancer drug evaluation by distinguishing between relative and fractional viability in in vitro assays, clarifying how drugs like Salinomycin impact proliferation versus cell death. These insights guide the design and interpretation of preclinical anti-cancer studies, improving reproducibility and the mechanistic understanding of drug actions.

• ICG001: Precision Wnt/β-Catenin Inhibition for Translational

  2026-06-08

  Explore how ICG001, a selective Wnt/β-catenin pathway inhibitor, empowers translational researchers to dissect CBP/β-catenin-driven mechanisms in cancer, fibrosis, and regenerative biology. This thought-leadership article integrates mechanistic insight, protocol guidance, and strategic vision, referencing the latest advances in Wnt signaling modulation and highlighting APExBIO’s product innovation.

• Sphingolipid Synthesis Inhibition Mitigates Ferroptosis via

  2026-06-07

  Liu et al. reveal that inhibiting sphingolipid synthesis with myriocin significantly reduces ferroptosis in neuronal cells by activating the HIF-1 pathway, specifically through HIF1α stabilization. This discovery identifies a novel neuroprotective mechanism with implications for mitigating regulated cell death in neurological disease models.

• Etomoxir in Fatty Acid Oxidation Pathway Research: Workflows

  2026-06-06

  Etomoxir (R-(+)-Etomoxir) is an essential tool for dissecting fatty acid oxidation and metabolic-immune interactions in both cell and whole-blood assays. This guide unpacks protocol enhancements, troubleshooting strategies, and applied data-driven use-cases, bridging bench research and translational immunometabolism. See how APExBIO's Etomoxir empowers reproducible, high-impact metabolic studies.

• Rotavirus Infection Downregulates Nrf2-Driven Redox Defense

  2026-06-05

  This study elucidates how progressive rotavirus infection disrupts cellular antioxidant defenses by sharply downregulating the transcription factor Nrf2 and its target genes. The findings highlight proteasome-mediated degradation as a critical mechanism and suggest new experimental angles for studying redox homeostasis in viral pathogenesis.

• Grazoprevir hydrate: Precision Tools for HCV Replication Inh

  2026-06-05

  Grazoprevir hydrate (MK-5172 hydrate) is transforming hepatitis C research with unparalleled potency against HCV genotypes 1 and 4, even in complex patient models. This article details optimized experimental workflows, data-driven troubleshooting, and translational insights for leveraging Grazoprevir hydrate in both bench and applied virology labs.

• PNU 74654 as a Wnt Signaling Pathway Inhibitor: Applied Work

  2026-06-04

  PNU 74654 empowers researchers to precisely modulate the Wnt/β-catenin axis in both cancer and stem cell contexts. This article translates recent breakthroughs in adipogenic and muscle progenitor assays into stepwise protocols and troubleshooting strategies, ensuring robust, reproducible results for advanced cell signaling research.

• CHIR-99021 (CT99021): Selective GSK-3 Inhibition in Stem Cel

  2026-06-04

  CHIR-99021 (CT99021) is a highly selective, cell-permeable inhibitor of GSK-3α/β, widely used to modulate Wnt/β-catenin signaling and maintain embryonic stem cell pluripotency. Peer-reviewed and product sources confirm its nanomolar potency and >500-fold kinase selectivity. This article details its mechanism, benchmarks, and best-practice applications for robust, reproducible stem cell workflows.

• ICG001: Deciphering Wnt/β-Catenin-Driven EMT and Fibrosis Me

  2026-06-03

  Discover how ICG001, a potent Wnt/β-catenin pathway inhibitor, enables advanced dissection of epithelial–mesenchymal transition (EMT) and fibrosis mechanisms. This article uniquely integrates recent mechanistic insights and protocol guidance for researchers seeking depth beyond standard workflows.

15783 records 5/1053 page Previous Next 12345 下5页 Last page